Table 1.
Sample | Concentration (μg/ml) | Cell viability (%) |
---|---|---|
Control | 0 | 100.0 ± 3.3 |
Aβ25-35 | 0.01 μM | 48.6 ± 5.1# |
Methanol extract | 0.5 | 70.4 ± 6.8 |
2.5 | 114.5 ± 5.5* | |
5.0 | 163.9 ± 10.8** | |
Water extract | 0.5 | 92.4 ± 8.8 |
2.5 | 106.9 ± 5.7* | |
5.0 | 122.3 ± 3.0** | |
95% Ethanol extract | 0.5 | 40.9 ± 5.7 |
2.5 | 62.5 ± 6.2 | |
5.0 | 71.2 ± 3.5 | |
Ellagic acid | 0.5 | 91.2 ± 7.8 |
2.5 | 98.4 ± 6.1* | |
5.0 | 105.1 ± 8.8* | |
AC-DEVD-CHO | 0.5 | 45.5 ± 7.9 |
2.5 | 64.0 ± 5.2 | |
5.0 | 94.6 ± 8.6 | |
Curcumin | 0.5 | 91.6 ± 3.2 |
2.5 | 93.5 ± 6.1 | |
5.0 | 102.0 ± 5.4* |
These data are showed as mean ± SD for 3 replicates.
P< 0.01 versus the control group without the addition of the sample and Aβ25-35 solutions,
P< 0.05;
P< 0.01 versus the μM Aβ25-35-treated group without the addition of the sample solution.